Table 6 Prevalence of Metabolic Syndrome in Iran based on Iranian Criteria
From: Prevalence of metabolic syndrome and its components in Iran: an updated meta-analysis
Criteria | Categories | No. study | Pooled prevalence (% 95 CI) | Heterogeneity assessment between studies | Publication bias assessments | ||||
|---|---|---|---|---|---|---|---|---|---|
I2 | P value | B | SE | P value | |||||
Iranian Criteria | Overall | 4 | 28% (21 − 36%) | 94.00% | < 0.001 | -2.15 | 2.016 | 0.2861 | |
Sex | Female | 2 | 33% (29 − 36%) | - | - | - | - | - | |
Male | 1 | 37% (29 − 45%) | - | - | - | - | - | ||
Age | 30–65 | 4 | 28% (21 − 36%) | 94.00% | < 0.001 | -2.15 | 2.016 | 0.2861 | |
Components | W_C | 2 | 47% (43 − 50%) | - | - | - | - | - | |
IFG | 2 | 31% (28 − 35%) | - | - | - | - | - | ||
TG | 2 | 35% (32 − 38%) | - | - | - | - | - | ||
HDL | 2 | 55% (52 − 58%) | - | - | - | - | - | ||
BP | 2 | 36% (33 − 40%) | - | - | - | - | - | ||